newsfilter
← Latest News
Business Wire·

Cortexyme Provides Business Update and Reports Second Quarter 2021 Results

GAIN Trial top-line data for disease modification in Alzheimer's expected by mid-November 2021 Phase 2 REPAIR sub-study results evaluating periodontal disease expected by mid-November 2021 Current cash position sufficient to fund operations throu